AGL Q3'26 Earnings: EPS estimate is (1.23) USD

What happened

Agilon health is scheduled to announce its Q3'26 results on November 4 after the market closes, with disclosure expected at 4:05 p.m. ET. The supplied estimate is revenue of 1.46 billion USD and earnings per share, or profit or loss per share, of negative 1.23.

Confirmed

Global impact / market context

The results will show whether agilon's reported revenue and earnings are near the estimates. Revenue below expectations could suggest weaker business activity, while a larger-than-expected loss per share could raise questions about costs and cash available to fund operations.

Analyst inference

The supplied table shows previous quarterly revenue estimates and reported figures, but does not provide Q3'26 results. Investors therefore have estimates, not confirmation of performance; the earnings release may change expectations about agilon's revenue and financial results.

Analyst inference

What to watch

1. Check the release after the scheduled November 4 announcement for reported revenue and earnings per share, then compare both figures with the supplied estimates. Confirmed
2. Listen for management's explanation of revenue trends and costs; any outlook or targets they provide are forward-looking statements, not confirmed future results. Analyst inference
3. Compare the reported loss per share with the estimated negative 1.23; a larger loss could point to pressure on earnings, though the release would be needed to identify why. Analyst inference

Evidence

• Original source link unavailable